Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union

ConclusionsMedication error safety concerns were listed for almost a quarter of centrally authorised products approved during the study period. Further research is needed to evaluate the effectiveness and continued need for additional risk minimisation measures for medication errors.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research